150cc Scooter. Global Automobiles, Kolkata-based Xenitis group on Thursday launched a 150 cc scooter called UFO 0150- a 4-stroke new generation state-of-the-art scooter in India priced at Rs 34,990.
The Group is also announced the national launch of Rock100 the 100cc motorcycle that has created revolution in the 2-wheeler market in India at a price of Rs 19,990.
Pranab Mukherjee, Hon’ble Union Minister, External Affairs, Govt of India unveiled the UFO 0150 and announced the national launch of Rock100 today in New Delhi in presence of Tariq Anwar, Hon’ble Member of Parliament & Member, Consultative Parliamentary Committee on External Affairs and Shri Anil Basu, Hon’ble Member of Parliament & Chairman, Indo-China Friendship Forum.
“We are entering the scooter market in India with UFO 0150. We
are eyeing 25% market share by 2010 with the help of our aggressive marketing strategy and pan India dealer network.
Global has built a strong dealer’s network of 450 dealers spanning across the country. It has 150 dealers in North India, 125 in West, 100 in South and 75 dealers in eastern India. The company has set up 250 exclusive showrooms across the country.
Xenitis Group, one of Eastern India’s biggest conglomerates set up its eastern India’s first and only 2-wheeler manufacturing factory in West Bengal in February, 2007.
Rock 100, the Revolutionary product, was launched in November ’07 in eastern India. Global has already sold 40,000 units of Rock 100 in eastern India in last few months. Rock 100 has all the potential to rock the 2-wheeler enthusiasts of India with its unbelievable Mileage of 125 km /litre and mass affordability factor.
“We are going aggressive for an all India roll out of this revolutionary Rock100 -the 100 cc performance motorcycle at lowest ever price point by any 2-wheeler manufacturer in India. We are confident to carve a niche for ourselves in the 7.6 million 2-wheeler market with our state-of-the-art technology, affordable pricing and strong distribution channel”, commented Mr. Santanu Ghosh, Chairman & MD, Xenitis Group.
No comments:
Post a Comment